Natural Bioactive Compounds in Rheumatoid Arthritis: Experimental Evidence from Adjuvant Arthritis Model Supporting Combination Strategies with Methotrexate. [PDF]
Umar M, Ahmad W, Bauerova K.
europepmc +1 more source
INDOMETHACIN: A NEW ANTIRHEUMATIC AGENT.
P J, BILKA, F, WOLLHEIM, R C, WILLIAMS
openaire +1 more source
Immune dysregulation and postoperative wound complications in systemic autoimmune rheumatic diseases: toward disease-specific risk stratification. [PDF]
Su ST, Wei JC.
europepmc +1 more source
Drug Retention of First-Line Biologic Therapies in Rheumatoid Arthritis: Real-World Evidence From a Moroccan Cohort. [PDF]
El Kacem EM +5 more
europepmc +1 more source
Risk-benefit considerations for antirheumatic drug use in pregnancy, breastfeeding, and male preconception: expert perspectives. [PDF]
Pluma A +6 more
europepmc +1 more source
[Rational use of antirheumatic agents].
T, Dürrigl, B, Vrhovac
openaire +1 more source
2. Antirheumatic Agents, 2) Biological Agents
openaire +2 more sources
Prevalence and clinical relevance of anti-drug antibodies in psoriatic arthritis: a systematic review. [PDF]
Kimpton J +6 more
europepmc +1 more source
Hematological Indices as Biomarkers in Patients With Rheumatoid Arthritis but Normal ESR/CRP Receiving Biological/Targeted Synthetic DMARDs. [PDF]
Jhou JP +4 more
europepmc +1 more source
Safety and effectiveness of rituximab biosimilar (Rituximab-GP2013) versus originator in rheumatoid arthritis: real-world evidence from a single center. [PDF]
Bayeh B +16 more
europepmc +1 more source

